Cajal Neuroscience’s $96 Million Series A Financing

Wilson Sonsini Goodrich & Rosati advised Cajal Neuroscience on the deal.Cajal Neuroscience Inc., a biotechnology company integrating human genetics, functional genomics, and advanced microscopy to discover…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now